1 / 39

Fiberoptic Bronchoscopy in the ICU

Fiberoptic Bronchoscopy in the ICU. R. Duncalf, MD, FCCP Pulmonary & Critical Care Division Bronx Lebanon Hospital Center. Introduction: Spectrum of Pulmonary Disease in the ICU. Pneumonia- community or nosocomial Pulmonary edema- cardiogenic or noncardiogenic

mariko
Télécharger la présentation

Fiberoptic Bronchoscopy in the ICU

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fiberoptic Bronchoscopy in the ICU R. Duncalf, MD, FCCP Pulmonary & Critical Care Division Bronx Lebanon Hospital Center

  2. Introduction: Spectrum of Pulmonary Disease in the ICU • Pneumonia- community or nosocomial • Pulmonary edema- cardiogenic or noncardiogenic • Pulmonary hemorrhage ± hemoptysis • Thromboembolic disease • Primary or metastatic CA • Interstitial lung disease • Obstructive airway disease • Respiratory failure in any of above requiring intubation and mechanical ventilation (MV) • Complications of intubation and MV

  3. Introduction: Flexible Fiberoptic Bronchoscopy (FFB) • Essential diagnostic and therapeutic tool in ICU • Can be performed via endotracheal tube (ETT) or tracheostomy tube • Bedside procedure: avoids transport/ OR time

  4. Common Diagnostic ICU Indications for FFB • Inspection, bronchoalveolar lavage (BAL), transbronchial lung biopsy (TBBx) • Abnormal chest X-ray/ suspected pulmonary infection • Hemoptysis • Lung carcinoma/ obstructing neoplasm • Chemical or thermal burns • ETT assessment/ management: intubation/extubation assist, position/ injury evaluation

  5. Feng A, Sy E. A Lung Saddle Tumor. The Internet Journal of Pulmonary Medicine 2009 : Volume 11 Number 1 Elderly patient admitted with respiratory failure. Bx= Squamous cell Ca

  6. Common Therapeutic ICU Indications for FFB • Retained secretions/ atelectasis • Mucous plugs- bronchial asthma, cystic fibrosis • Hemoptysis/ blood clots • Drainage lung abscess • Debridement of necrotic tracheobronchial mucosa • Dilation airway stenosis/ strictures

  7. Indications in Critically Ill Medical Patients 198 bronchoscopies: 45% retained secretions 35% specimens for culture 7% airway evaluation 2% hemoptysis Olapade CS, Prakash U: Bronchoscopy in the critical care unit. Mayo Clin Proc 64:1255-1263, 1989

  8. FFB in Pulmonary Infiltrates • Usually to evaluate infectious process • Allows directed sampling, identification of pathogens, de-escalation of antibiotics • BAL 10-50,000 CFU on culture diagnostic • protected specimen brush 5-10,000 CFU diagnostic • Potential for identification of noninfectious processes

  9. Middle age patient admitted with RLL pneumonia and DKA.

  10. Cos J, Sy E, Diaz-Fuentes G, Menon L. Foreign body presenting as a persistent lung infiltrate. The IJPM 2009 : Volume 11 Number 1

  11. Cos J, Sy E, Diaz-Fuentes G, Menon L. Foreign body presenting as a persistent lung infiltrate. The IJPM 2009 : Volume 11 Number 1 After removal of foreign body

  12. FFB in Retained Secretions and Atelectasis • FFB vs. physiotherapy for retained secretions: no superiority demonstrated • FFB in atelectasis: • retained secretions and air bronchograms to segmental level only • lobar or greater atelectasis not responding to aggressive chest PT • life threatening whole lung atelectasis • Severe hypoxemia not contraindication • Expect improved A-a gradient, static compliance, radiography (8 hrs)

  13. 3/24/10 3/26/10

  14. Emergent FFB in the ICU • 27% atelectasis/ retained secretions • 17% ARDS/ pulmonary edema • 13% airway stenosis/ tracheobronchomalacia • 13% pneumonia/ empyema • 8% hemoptysis • 8% foreign body Hasegawa S, Terada Y, Murakawa M, et al: Emergency bronchoscopy. Journal of bronchology 5: 284-287, 1998

  15. CXR after difficult intubation. Septic shock with MOD and AIDS

  16. Daniel V, DeLaCruz A, Diaz-Fuentes G. Tracheal Laceration Due to Endobronchial Intubation. Journal of Respiratory diseases. June 2007:15-17

  17. FFB: Complications • Premedication/ local anesthesia: respiratory depression/ arrest, methemoglobinemia, death • Procedure related: hypoxemia, cardiac complications, pneumonia, death • Ancillary procedures: barotrauma, pulmonary hemorrhage, death

  18. Complications: Hypoxemia • Common: up to 2 hrs. post procedure: 20-30 mmHg O2 drop in healthy, 30-60 in critically ill • Reduction in effective tidal volume and FRC • Suction at 100mmHg via 2mm suction port removes 7L/min • Saline/lidocaine instillation

  19. Safety of BAL in Ventilated Patients With ARDS J Bronchol Volume 14, Number 3, July 2007 148 ventilated patients with ARDS in ICU underwent FOB-BAL for investigation of VAP No deaths or major complications occurred in relation to BAL Only 2 minor episodes of desaturation (fall in SpO2 of 6%) occurred within two hours after BAL, a complication rate of 1.4% (P=0.49) FFB with BAL in ICU in ventilated ARDS patients (even with extreme hypoxemia ) is safe provided adequate precautions are taken

  20. Complications: Cardiac • Hypoxemia, hypercapnea increased sympathetic tone arrhythmias, ischemia, hypotension death • Major arrhythmias in 11% • Unstable angina, severe preexisting hypoxemia risk factors • Hemodynamics: 30% MAP, 43%HR, 28% CI

  21. FFB in MV: Physiology • Standard ED 5.7mm scope occludes 10% cross sectional area of trachea, 40% 9mm ID ETT, 51% 8mm ID ETT, 66% 7mm ID ETT • Hypoventilation, hypoxemia, gas trapping/ high intrinsic PEEP • 8mm ID ETT for standard scope recommended • Ultrathin bronchoscopes (2.8mm): reduce potential for hypoxemia/hypercapnea, dynamic hyperinflation

  22. FFB in MV: Increased Complication Risk • Pulmonary: • PaO2< 70mmHg with FiO2> 0.7 • PEEP> 10 cm H2O • autoPEEP > 15 cm H2O • active bronchospasm • Cardiac: • recent MI (48 hrs.) • unstable arrhythmia • MAP < 65mm Hg or vasopressor • CNS: • increased intracranial pressure

  23. FFB in MV: Complication Rates • < 10 % • Minor complications: 6.5% • Major complications: 0.08-0.15% • Mortality: 0.01-0.04% • Raoof S, Mehrishi S, Prakash U. Role of bronchoscopy in the modern medical intensive care unit. Clin Chest Med 2001; 22: 241-261

  24. FFB in MV: Complications of TBBx • Study of 83 lung biopsies: • 14.3% pneumothorax • 8.4% hypoxemia < 90% • 7.2% hypotension (MAP < 60mm Hg) • 6% hemorrhage > 30 cc • 3.6% tachycardia >140/min. O’Brien JD, Ettinger NA, Shevlin D et al: Safety yield of transbronchial lung biopsy in mechanically ventilated patients. Crit Care Med 25: 440-446 1997

  25. Yield and Safety of FFB and TBBX on patients on Mechanical Ventilation in the ICU Division of Pulmonary and Critical Care Medicine, Bronx- Lebanon Hospital Center, Bronx, NY

  26. There is limited information on the usefulness and safety of TBBx in ICU patients on MV • The goals of the study were to evaluate the yield, safety and efficacy of FFB with BAL and TBBx compared to FFB-BAL only • Retrospective review of ICU patients on MV who underwent diagnostic FFB from January 2006 to December 2007 • TBBx was done at the bedside and without fluoroscopic guidance • The average number of biopsies per patient were 2 (range 1-3) • Patients who underwent FFB for inspection and / or therapeutic bronchoscopy were excluded

  27. Demographics • 132 patients were identified: 92 in the BAL and 40 in the BAL with TBBx group • 48 (36%) of patients were HIV positive, all had AIDS • The main indications for FFB were evaluation of lung infiltrates (99%) and lung masses

  28. Overall Yield of FFB

  29. Comparison of yield between HIV and Non HIV group P value= 0.04 P value= 0.9

  30. Analysis of positive yield in the BAL with TBBx group

  31. Analysis of the yield for the BAL with TBBx positive in the Non-HIV patients

  32. Analysis of yield for the BAL with TBBx positive in HIV patients

  33. Results • There was no statistical difference in the yield from BAL when compared to BAL with TBBx for patients on MV • BAL alone showed a higher yield in patients with HIV as compared to non- HIV patients • More patients in the HIV positive group had BAL with TBBx compared with the non-HIV group ( 48% vs 20 % respectively) • TBBx revealed additional diagnosis in 4 patients: PCP (1), malignancy (1), and fungal infection (2) • There were no complications in either group

  34. Conclusions • The overall yield of diagnostic BAL with TBBx was 60%; this lower than reported yield could be due to inadequate biopsy sampling due to the non-fluoroscopic technique and/or to the fewer number of biopsies done • TBBx is a useful alternative for the diagnosis of infections in critically ill patients who are too ill for surgical biopsies; especially in HIV+/AIDS patients where fungal infection is often a consideration • We recommend considering BAL with TBBx in selected patients on MV, especially in HIV+/ AIDS patients, where opportunistic infections are suspected • FFB with BAL with TBBx seems to be a safe diagnostic tool in ICU patients on MV

  35. Thanks

More Related